Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs SK Hynix (SKHY) Price & Performance

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs SK Hynix — how do they compare? Heron Therapeutics Inc trades at $0.39 (market cap $68.01M), while SK Hynix trades at $170.33 (market cap $891.31B). The key difference: SK Hynix is far larger — about 13105.6× Heron Therapeutics Inc's market cap, and SK Hynix pays a 0.06% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and SK Hynix for 10 Days on average.

HRTXSKHY
Market Cap
$68.01M$891.31B
Volume
1,891,94122,268,296
Sector
HealthTechnology
52-Week High
$1.49$198.63
52-Week Low
$0.27$126.79
Typical Hold Time
35 Days10 Days
Enterprise Value
$174.75M$841.45B
Dividend Yield
—0.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.

While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.

SK Hynix

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
SKHY
63% Buy37% Sell
Avg holding period · 10 Days

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About SK Hynix

SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.

Read more on SKHY →